HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

4th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 19-21 | Hybrid Event

September 19-21, 2024 | Rome, Italy
ECBB 2024

Rahul Hajare

Rahul Hajare, Speaker at Bioengineering Conferences
Sandip University Nashik, India
Title: Hepatitis b and delta co-infection: Prevalence and serological characteristics in India


Introduction: HBV infection is the tenth leading cause of death worldwide, accounting for between 580,000 and 1.2 million deaths per year and approximately 8% of all HBV carriers worldwide are co-infected with the virus hepatitis delta (HDV). In Africa, about a quarter of the 68 million chronic carriers of HBV are suspected of being co-infected with HDV. In India, some authors have described a high prevalence of HDV infection in previous years. The objective of this work has to assess the prevalence of HBV and HDV co-infection, the influence of co-infection on B viral load, the relationship between HBe seroconversion and HBV viral load and the influence of HBV/HDV co-infection on HBe seroconversion, as well as the study of other biological parameters. The prevalence of HBV/HDV co-infection is 38.30% in our series of 211 patients with HBsAg, the distribution by sex reports a male predominance with a sex ratio of 1.45. The average age was 36 years old. The average HBV viral load was 4.68 ± 1.31 log IU/ml (i.e. 478.64 IU/ml ± 20.41). 98.9% of patients have HBeAg (-) and 5.4% were HBeAg (+). The prevalence of HBV/HDV co-infection is high in our country, reaching 31.4% of HBsAg positive subjects. The average age was 38years, the sex ratio M/F is 1.44. The HBe status is strongly correlated with the amount of DNA levels of our patients while the HBV viral load was not significantly different in AC HDV positive patients compared to AC HDV negative patients.


Dr. Rahul Hajare studied Pharmaceutical Chemistry at the Amravati University, India and graduated as B.Pharm in 2002. He then joined the research group of Institute of Pharmaceutical Research and Education and Quality Assurance, Nagpur University. He received his PhD degree in 2012 at the Vinayaka Mission University. After two year postdoctoral fellowship supervised by Renowned and Scientist Respected Dr. Ramesh Paranjape at the National AIDS Research Institute ICMR Pune India. He obtained the position of an Associate Professor at the G H Raisoni University Amravati GHRU.He has published more than 70 research articles in SCI(E) journals.).Dr. Rahul Hajare is awarded by Scholar Hindu University of America.